Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Icon Plc (ICLR)

Icon Plc (ICLR)
142.72 +5.93 (+4.34%) 15:20 ET [NASDAQ]
142.55 x 100 142.82 x 16
Realtime by (Cboe BZX)
142.55 x 100 142.82 x 16
Realtime 139.18 +2.39 (+1.75%) 09:28 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
138.48
Day High
146.93
Open 138.49
Previous Close 136.79 136.79
Volume 1,376,907 1,376,907
Avg Vol 1,451,338 1,451,338
Stochastic %K 15.29% 15.29%
Weighted Alpha -55.47 -55.47
5-Day Change -2.38 (-1.64%) -2.38 (-1.64%)
52-Week Range 133.28 - 347.72 133.28 - 347.72
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,046,750
  • Shares Outstanding, K 80,757
  • Annual Sales, $ 8,282 M
  • Annual Income, $ 791,470 K
  • EBIT $ 1,586 M
  • EBITDA $ 2,075 M
  • 60-Month Beta 1.24
  • Price/Sales 1.34
  • Price/Cash Flow 6.85
  • Price/Book 1.16

Options Overview Details

View History
  • Implied Volatility 68.49% ( +3.68%)
  • Historical Volatility 52.80%
  • IV Percentile 97%
  • IV Rank 92.76%
  • IV High 71.90% on 04/10/25
  • IV Low 24.77% on 08/16/24
  • Put/Call Vol Ratio 0.38
  • Today's Volume 40
  • Volume Avg (30-Day) 165
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 2,028
  • Open Int (30-Day) 2,614

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 2.98
  • Number of Estimates 5
  • High Estimate 3.11
  • Low Estimate 2.90
  • Prior Year 3.38
  • Growth Rate Est. (year over year) -11.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
133.28 +7.13%
on 04/22/25
Period Open: 184.87
188.05 -24.07%
on 03/24/25
-42.09 (-22.77%)
since 03/21/25
3-Month
133.28 +7.13%
on 04/22/25
Period Open: 202.68
208.95 -31.67%
on 02/21/25
-59.90 (-29.55%)
since 01/23/25
52-Week
133.28 +7.13%
on 04/22/25
Period Open: 306.45
347.72 -58.94%
on 07/16/24
-163.67 (-53.41%)
since 04/23/24

Most Recent Stories

More News
Do Options Traders Know Something About ICON (ICLR) Stock We Don't?

Investors in ICON plc ICLR need to pay close attention to the stock based on moves in the options market lately. That is because the April 17, 2025 $350.00 Call had some of the highest implied volatility...

ICLR : 142.72 (+4.34%)
ICLR Q4 Earnings and Revenues Beat, Stock Rises at After-Market

ICON plc ICLR delivered fourth-quarter 2024 adjusted earnings per share of $3.43, down 0.9% from the year-ago period’s reported figure. However, the metric surpassed the Zacks Consensus Estimate marginally...

ICLR : 142.72 (+4.34%)
DGX : 173.13 (+0.17%)
RMD : 215.26 (+0.55%)
CAH : 134.10 (+0.31%)
Icon PLC: Q4 Earnings Snapshot

Icon PLC: Q4 Earnings Snapshot

ICLR : 142.72 (+4.34%)
Icon PLC: Q3 Earnings Snapshot

Icon PLC: Q3 Earnings Snapshot

ICLR : 142.72 (+4.34%)
Implied Volatility Surging for ICON (ICLR) Stock Options

Investors in ICON Public Limited Company ICLR need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 18, 2024 $145 Call had some of the highest implied...

ICLR : 142.72 (+4.34%)
Icon PLC: Q2 Earnings Snapshot

Icon PLC: Q2 Earnings Snapshot

ICLR : 142.72 (+4.34%)
Icon PLC: Q1 Earnings Snapshot

Icon PLC: Q1 Earnings Snapshot

ICLR : 142.72 (+4.34%)
Icon PLC: Q4 Earnings Snapshot

Icon PLC: Q4 Earnings Snapshot

ICLR : 142.72 (+4.34%)
3 Growth Stocks to Buy That Could Be Massive Long-Term Winners

A red-hot product or service right now doesn't mean much if demand for it isn't going to last.

NVDA : 102.74 (+3.89%)
ICLR : 142.72 (+4.34%)
NVO : 61.13 (+2.04%)
Icon PLC: Q3 Earnings Snapshot

Icon PLC: Q3 Earnings Snapshot

ICLR : 142.72 (+4.34%)
Icon PLC: Q2 Earnings Snapshot

Icon PLC: Q2 Earnings Snapshot

ICLR : 142.52 (+4.19%)
Icon PLC: Q1 Earnings Snapshot

Icon PLC: Q1 Earnings Snapshot

ICLR : 142.52 (+4.19%)
ICON Reports First Quarter 2023 Results

ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the first quarter ended March 31, 2023.

ICLR : 142.52 (+4.19%)
ICON plc Schedules First Quarter 2023 Earnings Conference Call

ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the first quarter 2023 after the market...

ICLR : 142.52 (+4.19%)
2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch

These companies strive to bring down the cost of developing new therapies.

ICLR : 142.52 (+4.19%)
CTLT : 63.48 (unch)
DHR : 196.79 (+2.46%)
IQV : 146.67 (+2.13%)
Should You Bring The Luck Of The Irish To Your Investmets?

An index of Irish stocks is outperforming the S&P 500 this year, with large, U.S.-listed companies such as Ryan Air and CRH among top price performers.

KRYAF : 106.0000 (+2.91%)
ICLR : 142.52 (+4.19%)
CRH : 88.13 (+2.81%)
PDYPY : 103.7500 (+0.50%)
BKRIY : 12.1750 (+4.15%)
GLAPF : 11.4420 (+1.71%)
RYAAY : 46.45 (+1.00%)
EIRL : 59.58 (+1.36%)
KGSPF : 78.1500 (-0.27%)
DEO : 110.39 (-1.76%)
LEO Pharma and ICON Enter a Strategic Partnership to Propel Clinical Trial Execution Within Medical Dermatology

LEO Pharma , a global leader in medical dermatology, and ICON plc (NASDAQ: ICLR) today announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric...

ICLR : 142.52 (+4.19%)
ICON plc to Present at Upcoming Investor Conferences

ICON plc , (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the 2023 Citi Healthcare...

ICLR : 142.52 (+4.19%)
Icon PLC: Q4 Earnings Snapshot

Icon PLC: Q4 Earnings Snapshot

ICLR : 142.52 (+4.19%)
ICON Reports Fourth Quarter and Full Year 2022 Results

ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the fourth quarter and year ended December 31, 2022.

ICLR : 142.52 (+4.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

See More

Key Turning Points

3rd Resistance Point 143.72
2nd Resistance Point 140.93
1st Resistance Point 138.86
Last Price 142.72
1st Support Level 134.00
2nd Support Level 131.21
3rd Support Level 129.14

See More

52-Week High 347.72
Fibonacci 61.8% 265.81
Fibonacci 50% 240.50
Fibonacci 38.2% 215.20
Last Price 142.72
52-Week Low 133.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective